Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epacadostat combinations in advanced malignancies
NCT03347123Phase 2Terminated
- Sponsor
- Incyte
- Start
- Mar 2018
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of epacadostat in solid tumor, melanoma, non-small cell lung cancer (NSCLC), squamous cell carcinoma of the head and neck (HNSCC), sponsored by Incyte. Started Mar 2018; status: terminated.
02
Drugs
epacadostat
03
Conditions
solid tumormelanomanon-small cell lung cancer (NSCLC)squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT03347123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03347123.